Leading dry ice specialist Cold Jet is urging the industry to upgrade its equipment and optimise production, as the hot topic of a Covid-19 vaccine continues to gather pace.
Earlier this week (11th November) gasworld exclusively reported how dry ice producers, distributors and equipment makers are bracing themselves for a spike in demand next year, with concerns there will be a tightening in the availability of dry ice for storage and distribution of Covid-19 vaccines.
Read more: Dry ice set for spike in demand
It followed the news from Pfizer and BioNTech that the vaccine they had developed had shown strong results in medical trials; early data of tests on more than 40,000 people around the world suggests the vaccine protects over 90% of people from the virus. No safety concerns had yet been raised.
The pharmaceuticals giant and the German biotechnology company reportedly plan to apply for emergency medical approvals for the vaccine by the end of the month, with suggestions that deliveries could start to be made by the end of the year. The EU is understood to have agreed to buy up to 300 million doses of the vaccine, while the UK Government this week indicated its own roll-out of the vaccine could begin as early as December.
... to continue reading you must be a member